Show simple item record

dc.contributor.advisorSheppard, Brian
dc.contributor.authorO'Toole, Sharon A.
dc.date.accessioned2017-01-03T13:18:19Z
dc.date.available2017-01-03T13:18:19Z
dc.date.issued2003
dc.identifier.citationSharon A. O'Toole, 'Predicting the response of gynaecological tumours to chemotherapy', [thesis], Trinity College (Dublin, Ireland). School of Medicine. Discipline of Obstetrics and Gynaecology, 2003, pp 380
dc.identifier.otherTHESIS 7377
dc.description.abstractThe aim of this study was to use an in vitro (3-(4,5-dimethylthiazol-2-yl)-5-(3- carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt) (MTS) assay in combination with an explant culture technique to determine the response of ovarian, endometrial and cervical tumours to various cytotoxic drugs and correlate this with the in vivo response. Three candidate markers, CD31, VEGF (vascular endothelial growth factor) and MDR1 (multidrug resistance 1) were assessed to determine if they could predict the response to chemotherapy in ovarian cancers or act as prognostic factors.
dc.format1 volume
dc.language.isoen
dc.publisherTrinity College (Dublin, Ireland). School of Medicine. Discipline of Obstetrics and Gynaecology
dc.relation.isversionofhttp://stella.catalogue.tcd.ie/iii/encore/record/C__Rb12399670
dc.subjectObstetrics, Ph.D.
dc.subjectPh.D. Trinity College Dublin
dc.titlePredicting the response of gynaecological tumours to chemotherapy
dc.typethesis
dc.type.supercollectionthesis_dissertations
dc.type.supercollectionrefereed_publications
dc.type.qualificationlevelDoctoral
dc.type.qualificationnameDoctor of Philosophy (Ph.D.)
dc.rights.ecaccessrightsopenAccess
dc.format.extentpaginationpp 380
dc.description.noteTARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie
dc.identifier.urihttp://hdl.handle.net/2262/78583


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record